Author

Alba De Martino

Instituto de Investigación Sanitaria AragónORCID 0000-0002-2436-9852Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Álvaro Andreu-BernabeuiD· 1 shared Álvaro OteroiD· 1 shared Amanda Fernández‐RodrígueziD· 1 shared Anabel Liger Borja· 1 shared André Ducati LuchessiiD· 1 shared Ángel Martínez-PéreziD· 1 shared Anna González‐NeiraiD· 1 shared Antonio CubilloiD· 1 shared

Activity by Year

2017-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Álvaro Andreu-BernabeuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Novel risk loci for COVID-19 hospitalization among admixed American populations

Silvia Diz‐de Almeida, Raquel Cruz, André Ducati Luchessi, Jose Miguel Lorenzo-Salazar, Miguel López de Heredia, Inés Quintela, Rafaela González‐Montelongo, Vivian Nogueira Silbiger, Marta Sevilla Porras, Jair Antonio Tenorio, Julián B. Nevado, José María Aguado, Carlos Aguilar, Sergio Aguilera, Virginia Almadana Pacheco, , Juan Carlos Souto

This study identifies novel genetic risk loci for COVID-19 hospitalization in admixed American populations through a large GWAS.

eLife · Sep 16, 2024Peer-reviewedGenetic & Genomic Medicine

Whole-exome sequencing of plasma cell-free DNA portrays the somatic mutation landscape of refractory metastatic colorectal cancer and enables the discovery of mutated KDR/VEGFR2 receptors as modulators of anti-angiogenic therapies.

Rodrigo Almeida Toledo, Elena Garralda, Maria Mitsi, Tirso Pons, Jorge Monsech, Estela Vega, Álvaro Otero, Maria Isabel Albarran, Natalia Baños, Yolanda Durán, Victoria Bonilla, Francesca Sarno, Marta Camacho‐Artacho, Tania Sánchez‐Pérez, Sofia Hidalgo Perea, , Manuel M. Hidalgo

This study uses whole-exome sequencing of plasma cell-free DNA to analyze somatic mutations in metastatic colorectal cancer and identifies KDR/VEGFR2 mutations affecting anti-angiogenic therapy response.

bioRxiv · Aug 28, 2017 · PreprintGenomics